The successful training program in Bioinformatics and Integrative Genomics (BIG) has been transferred from the MIT-Harvard Division of Health Sciences and Technology to the Harvard Medical School Division of Medical Sciences (DMS). This entails incremental changes in the curriculum, because of full cross-registration and a change in focus of the clinical experience away from general physiology and towards medical genetic clinics, and clinical genetics laboratory experience. BIG continues to focus on the growing gap between the ability to generate copious amounts genomic data and the ability to systematically and efficiently make sense of all this data, particularly for clinical relevance. Ths program admits students with proven excellence in quantitative science and seeks to train competent, multi-disciplinary investigators who are capable of both integrating the genome-scale technologies into their experimental investigations, and synthesizing the resulting datasets into coherent knowledge frameworks and mathematical models for formulating and resolving fundamental questions in biology and medicine. The BIG training program draws on three significant strengths of the local academic environment: the breadth of talented investigators at Harvard, the Medical School and affiliated hospitals, and MIT, the rich variety of quantitatively-oriented courses in advanced genomics-bioinformatics offered at Harvard and MIT, and national leadership of BIG faculty in harnessing clinical processes and electronic health records for genome-scale disease research. As a new track within DMS, the BIG pre-doctoral program provides a three legged curriculum: 1) rigorous course work in machine learning, probability theory, decision science, and biostatistics 2) in-depth courses that include the range of genome-scale measurements applied to population studies, clinical medicine and basic biology 3) survey of the larger scope of biomedical sciences as well as a rich, unique clinical experience focused on genetics clinics and genetic laboratory testing.
Integrating genomics into the practice of medicine and biomedical research is a primary goal of the National Human Genome Research Institute's strategic plan. The Harvard University Bioinformatics and Integrative Genomics (BIG) Program meets this goal by providing students trained in the quantitative sciences the intellectual tools t integrate genomics with medical science, access to big data from healthcare systems to experiment with methods of leveraging healthcare data in genomic science, faculty who are leading efforts to integrate genome-scale results into clinical practice, and faculty who are expert in genomics and bioinformatics.
|Manrai, Arjun K; Funke, Birgit H; Rehm, Heidi L et al. (2016) Genetic Misdiagnoses and the Potential for Health Disparities. N Engl J Med 375:655-65|
|Bandopadhayay, Pratiti; Ramkissoon, Lori A; Jain, Payal et al. (2016) MYB-QKI rearrangements in angiocentric glioma drive tumorigenicity through a tripartite mechanism. Nat Genet 48:273-82|
|Zhang, Danfeng; Gomez, James E; Chien, Jung-Yien et al. (2016) Genomic analysis of the evolution of fluoroquinolone resistance in Mycobacterium tuberculosis prior to tuberculosis diagnosis. Antimicrob Agents Chemother :|
|Wala, Jeremiah; Zhang, Cheng-Zhong; Meyerson, Matthew et al. (2016) VariantBam: filtering and profiling of next-generational sequencing data using region-specific rules. Bioinformatics 32:2029-31|
|Han, Buhm; Pouget, Jennie G; Slowikowski, Kamil et al. (2016) A method to decipher pleiotropy by detecting underlying heterogeneity driven by hidden subgroups applied to autoimmune and neuropsychiatric diseases. Nat Genet 48:803-10|
|Campbell, Joshua D; Alexandrov, Anton; Kim, Jaegil et al. (2016) Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet 48:607-16|
|Chen, Jenny; Shishkin, Alexander A; Zhu, Xiaopeng et al. (2016) Evolutionary analysis across mammals reveals distinct classes of long non-coding RNAs. Genome Biol 17:19|
|Taylor, Noah D; Garruss, Alexander S; Moretti, Rocco et al. (2016) Engineering an allosteric transcription factor to respond to new ligands. Nat Methods 13:177-83|
|Wala, Jeremiah; Beroukhim, Rameen (2016) CANCER. The oncogene makes its escape. Science 351:1398-9|
|Doores, Katie J; Kong, Leopold; Krumm, Stefanie A et al. (2015) Two classes of broadly neutralizing antibodies within a single lineage directed to the high-mannose patch of HIV envelope. J Virol 89:1105-18|
Showing the most recent 10 out of 60 publications